Fund comparison · from official SEC filings

IBB vs IBRN: how much do they overlap?

iShares Biotechnology ETF and iShares Neuroscience and Healthcare ETF
Holdings overlap
18%
of assets, by weight
Shared positions
36
of 253 / 84 holdings
IBB expense ratio
0.44%
net, per year
IBRN expense ratio
0.47%
net, per year
Shared holdings
Company
IBB
IBRN
B
BISXXBCF INSTITUTIONAL-SL AGNCY
11.65%
7.89%
X
XENEXENON PHARMACEUTICALS INC
0.26%
4.41%
A
AXSMAXSOME THERAPEUTICS INC
0.44%
4.23%
A
ARWRARROWHEAD PHARMACEUTICALS IN
0.39%
4.06%
A
ALKSALKERMES PLC
0.42%
3.87%
2
260CENTESSA PHARMACEUTICALS-ADR
0.13%
3.64%
A
ARGXARGENX SE - ADR
2.78%
3.58%
P
PTCTPTC THERAPEUTICS INC
0.41%
3.40%
N
NBIXNEUROCRINE BIOSCIENCES INC
1.19%
3.39%
B
BIIBBIOGEN INC
1.80%
3.38%
S
SRRKSCHOLAR ROCK HOLDING CORP
0.24%
3.38%
P
PRAXPRAXIS PRECISION MEDICINES I
0.09%
3.37%
A
ACAACADIA PHARMACEUTICALS INC
0.31%
3.33%
D
DNLIDENALI THERAPEUTICS INC
0.16%
2.60%
E
EWTXEDGEWISE THERAPEUTICS INC
0.11%
2.33%
D
DYNDYNE THERAPEUTICS INC
0.12%
2.18%
S
SRPTSAREPTA THERAPEUTICS INC
0.16%
2.04%
T
TSHATAYSHA GENE THERAPIES INC
0.06%
1.41%
B
BHVNBIOHAVEN LTD
0.12%
1.20%
R
RAPPRAPPORT THERAPEUTICS INC
0.05%
0.95%
A
ANNXANNEXON INC
0.03%
0.74%
P
PRTAPROTHENA CORP PLC
0.04%
0.47%
S
SLDBSOLID BIOSCIENCES INC
0.03%
0.43%
D
DSGNDESIGN THERAPEUTICS INC
0.02%
0.42%
R
RGNXREGENXBIO INC
0.04%
0.40%
Only in IBB
V
VRTXVERTEX PHARMACEUTICALS INC
6.77%
G
GILDGILEAD SCIENCES INC
6.64%
A
AMGNAMGEN INC
6.63%
R
REGNREGENERON PHARMACEUTICALS
5.03%
A
ALNYALNYLAM PHARMACEUTICALS INC
5.02%
I
IQVIQVIA HOLDINGS INC
2.81%
I
INSMINSMED INC
2.61%
M
MTDMETTLER-TOLEDO INTERNATIONAL
2.20%
N
NTRANATERA INC
1.87%
O
ONCBEONE MEDICINES LTD-ADR
1.86%
U
UTHRUNITED THERAPEUTICS CORP
1.61%
W
WATWATERS CORP
1.56%
I
INCYINCYTE CORP
1.43%
I
ILMNILLUMINA INC
1.24%
G
GMABGENMAB A/S -SP ADR
1.22%
M
MEDPMEDPACE HOLDINGS INC
1.02%
E
EXELEXELIXIS INC
0.94%
I
IONSIONIS PHARMACEUTICALS INC
0.91%
B
BMRNBIOMARIN PHARMACEUTICAL INC
0.90%
M
MDGLMADRIGAL PHARMACEUTICALS INC
0.81%
M
MRNAMODERNA INC
0.78%
T
TECHBIO-TECHNE CORP
0.75%
A
ASNDASCENDIS PHARMA A/S
0.74%
H
HALOHALOZYME THERAPEUTICS INC
0.74%
B
BBIOBRIDGEBIO PHARMA INC
0.74%
Only in IBRN
D
DNTHDIANTHUS THERAPEUTICS INC
3.12%
?
CATALYST PHARMACEUTICALS, INC.
3.03%
S
SUPNSUPERNUS PHARMACEUTICALS INC
2.56%
A
AXGNAXOGEN INC
2.15%
3
326030SK BIOPHARMACEUTICALS CO LTD
1.88%
H
HLBBFH LUNDBECK A/S
1.77%
C
CAPRCAPRICOR THERAPEUTICS INC
1.61%
B
BRCTFBIOARCTIC AB
1.26%
N
NURPFNEUREN PHARMACEUTICALS LTD
0.97%
T
TDVXFDYNAVOX GROUP AB
0.86%
D
DRUGBRIGHT MINDS BIOSCIENCES INC
0.84%
I
IDRSFIDORSIA LTD
0.80%
A
ANROALTO NEUROSCIENCE INC
0.72%
S
SNBIFSANBIO CO LTD
0.69%
I
IARTINTEGRA LIFESCIENCES HOLDING
0.69%
M
MDCLFMEDINCELL SA
0.60%
L
LBRXLB PHARMACEUTICALS INC
0.58%
B
BWAYBRAINSWAY LTD-ADR
0.55%
C
CBLLCERIBELL INC
0.48%
2
2190ZYLOX-TONBRIDGE MEDICAL TE-H
0.47%
4
4588ONCOLYS BIOPHARMA INC
0.45%
R
RLMDRELMADA THERAPEUTICS INC
0.45%
2
2172MICROPORT NEUROSCIENTIFIC CO
0.43%
N
NPCENEUROPACE INC
0.42%
B
BNTCBENITEC BIOPHARMA INC
0.39%
Hold IBB and IBRN together? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.